FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093417255> ?p ?o ?g. }

• W2093417255 endingPage "261" @default.
• W2093417255 startingPage "261" @default.
• W2093417255 abstract "Letters and Corrections1 August 1989Pancytopenia and Methotrexate with Trimethoprim- SulfamethoxazoleM. E. Jeurissen, MD, A.M. Boerbooms, MD, PhD, L.B. van de Putte, MD, PhDM. E. Jeurissen, MDSearch for more papers by this author, A.M. Boerbooms, MD, PhDSearch for more papers by this author, L.B. van de Putte, MD, PhDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-111-3-261_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editor: Kozarek and colleagues (1) found a dramatic clinical improvement in patients treated with methotrexate who had refractory Crohn colitis and an incomplete remission of chronic ulcerative colitis. Of 21 patients, 14 were also receiving either sulfasalazine or metronidazole (exact number of patients not mentioned).The risk of bone marrow suppression is increased when other antifolate drugs (derivatives of sulfonamides, trimethoprim) are used simultaneously with methotrexate. Besides additive folate antagonism, other pharmacologic mechanisms, such as competition with tubular secretion and displacement from albumin binding sites, play an important role in interactions of sulfonamides and methotrexate. Moreover, it was...References1. KozarekPattersonGelfandBotomanBallWilsh RDMVTK. Methotrexate induces clinical and histological remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 1989;110:353-6. LinkGoogle Scholar2. HalsteadGhandiTamura CGT. Sulphasalazine inhibits the absorption of folates in ulcerative colitis. N Engl J Med. 1981;305:1513-7. CrossrefMedlineGoogle Scholar3. MaricicDavisGall MME. Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim-sulfamethoxazole treatment. Arthritis Rheum. 1986;29:133-5. CrossrefMedlineGoogle Scholar4. ThomasGutterman ML. Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole. J Rheum. 1986;13:440-1. MedlineGoogle Scholar5. MacKinnonStarkebaumWillkens SGR. Pancytopenia associated with low pulse methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum. 1985;15:119-26. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: University Hospital Nijmegen 6525 GA Nijmegen The Netherlands PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA Survey of the Adverse Effects and Influence of Concomitant Drugs for Methotrexate Intrathecal AdministrationEffect of ceftriaxone and cefepime on high-dose methotrexate clearanceMethotrexateTrimethoprim and co-trimoxazoleCytostatic and cytotoxic drugsDisease-Modifying Antirheumatic Drug Use in Older Rheumatoid Arthritis PatientsMethotrexate Drug Interactions in the Treatment of Rheumatoid Arthritis: A Systematic ReviewCanadian Recommendations for Use of Methotrexate in Patients with Rheumatoid ArthritisDRUGS USED IN CANCER CHEMOTHERAPYANTIBACTERIAL DRUGSGLUCOCORTICOIDS AND DISEASE – MODIFYING ANTIRHEUMATIC DRUGSRole and place of methotrexate in vasculitis managementMethotrexate: Understanding the risk in psoriasis patientsClinically Significant Drug–Drug Interactions Between Oral Anticancer Agents and Nonanticancer Agents: Profiling and Comparison of Two Drug CompendiaMethotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprimMethotrexateA guide to clinically relevant drug interactions in oncologyPharmacokinetics and Pharmacodynamics of Methotrexate in Non-Neoplastic DiseasesSevere Pancytopenia Associated with Low-Dose Methotrexate Therapy for Rheumatoid ArthritisMethotrexate as an alternative to classic immunosuppressive therapiesHigh-Dose Methotrexate–Doxycycline InteractionToxicity Profile of Methotrexate in Rheumatoid ArthritisMethotrexate in rheumatoid arthritis: An updatewith focus on mechanisms involved in toxicityPHARMACOLOGY AND PHARMACOKINETICS OF METHOTREXATE IN RHEUMATIC DISEASEMETHOTREXATE USE IN SYSTEMIC VASCULITISTHE REMARKABLE SPECTRUM OF METHOTREXATE TOXICITIESPancytopenia secondary to methotrexate therapy in rheumatoid arthritisTreatment of psoriasis with cytotoxic drugsNeutropenia due to low‐dose methotrexate therapy for psoriasis and rheumatoid arthritis may be fatalMiscellaneous antibacterial and antiviral drugs 1 August 1989Volume 111, Issue 3Page: 261-261KeywordsAlbuminsBone marrowColitisDrugsFolic acidMethotrexateSulfonamideUlcerative colitis Issue Published: 1 August 1989 PDF downloadLoading ..." @default.
• W2093417255 created "2016-06-24" @default.
• W2093417255 creator A5083785398 @default.
• W2093417255 date "1989-08-01" @default.
• W2093417255 modified "2023-09-24" @default.
• W2093417255 title "Pancytopenia and Methotrexate with Trimethoprim- Sulfamethoxazole" @default.
• W2093417255 cites W1976393913 @default.
• W2093417255 cites W2003106549 @default.
• W2093417255 cites W57720233 @default.
• W2093417255 doi "https://doi.org/10.7326/0003-4819-111-3-261_1" @default.
• W2093417255 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2787612" @default.
• W2093417255 hasPublicationYear "1989" @default.
• W2093417255 type Work @default.
• W2093417255 sameAs 2093417255 @default.
• W2093417255 citedByCount "34" @default.
• W2093417255 countsByYear W20934172552014 @default.
• W2093417255 countsByYear W20934172552016 @default.
• W2093417255 crossrefType "journal-article" @default.
• W2093417255 hasAuthorship W2093417255A5083785398 @default.
• W2093417255 hasConcept C126322002 @default.
• W2093417255 hasConcept C2778260677 @default.
• W2093417255 hasConcept C2778397455 @default.
• W2093417255 hasConcept C2779134260 @default.
• W2093417255 hasConcept C2779382419 @default.
• W2093417255 hasConcept C2779383735 @default.
• W2093417255 hasConcept C2780007613 @default.
• W2093417255 hasConcept C2780479503 @default.
• W2093417255 hasConcept C2780728791 @default.
• W2093417255 hasConcept C2781059491 @default.
• W2093417255 hasConcept C2781382166 @default.
• W2093417255 hasConcept C501593827 @default.
• W2093417255 hasConcept C71924100 @default.
• W2093417255 hasConcept C86803240 @default.
• W2093417255 hasConcept C89423630 @default.
• W2093417255 hasConcept C90924648 @default.
• W2093417255 hasConcept C98274493 @default.
• W2093417255 hasConceptScore W2093417255C126322002 @default.
• W2093417255 hasConceptScore W2093417255C2778260677 @default.
• W2093417255 hasConceptScore W2093417255C2778397455 @default.
• W2093417255 hasConceptScore W2093417255C2779134260 @default.
• W2093417255 hasConceptScore W2093417255C2779382419 @default.
• W2093417255 hasConceptScore W2093417255C2779383735 @default.
• W2093417255 hasConceptScore W2093417255C2780007613 @default.
• W2093417255 hasConceptScore W2093417255C2780479503 @default.
• W2093417255 hasConceptScore W2093417255C2780728791 @default.
• W2093417255 hasConceptScore W2093417255C2781059491 @default.
• W2093417255 hasConceptScore W2093417255C2781382166 @default.
• W2093417255 hasConceptScore W2093417255C501593827 @default.
• W2093417255 hasConceptScore W2093417255C71924100 @default.
• W2093417255 hasConceptScore W2093417255C86803240 @default.
• W2093417255 hasConceptScore W2093417255C89423630 @default.
• W2093417255 hasConceptScore W2093417255C90924648 @default.
• W2093417255 hasConceptScore W2093417255C98274493 @default.
• W2093417255 hasIssue "3" @default.
• W2093417255 hasLocation W20934172551 @default.
• W2093417255 hasLocation W20934172552 @default.
• W2093417255 hasOpenAccess W2093417255 @default.
• W2093417255 hasPrimaryLocation W20934172551 @default.
• W2093417255 hasRelatedWork W2044543470 @default.
• W2093417255 hasRelatedWork W2069883074 @default.
• W2093417255 hasRelatedWork W2073104311 @default.
• W2093417255 hasRelatedWork W2073759704 @default.
• W2093417255 hasRelatedWork W2076390064 @default.
• W2093417255 hasRelatedWork W2086360535 @default.
• W2093417255 hasRelatedWork W2355625439 @default.
• W2093417255 hasRelatedWork W2391276119 @default.
• W2093417255 hasRelatedWork W2392278512 @default.
• W2093417255 hasRelatedWork W2735068 @default.
• W2093417255 hasVolume "111" @default.
• W2093417255 isParatext "false" @default.
• W2093417255 isRetracted "false" @default.
• W2093417255 magId "2093417255" @default.
• W2093417255 workType "article" @default.